Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Jonathan Epstein MD

Jonathan I. Epstein MD

Professor of Pathology, Urology, and Oncology, Reinhard Chair of Urological Pathology, and Director of Surgical Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland

Dr. Epstein received training in Pathology at Johns Hopkins with a fellowship in Memorial Sloan Kettering Cancer Center. He is the past President of the International Society of Urological Pathology. Dr. Epstein has >900 publications (H-factor – 141), 71 book chapters, and 17 books. He has one of the largest surgical pathology consulting services in the world with approximately 12,000 cases per year, covering the full range of urologic pathology. Dr Epstein trains 4 genitourinary pathology fellows each year, with 71 fellows trained to date. He has lectured 387 times outside of his institution including 42 different countries. His passion outside of his work is photography in the many countries he has been fortunate to visit.

Recent Contributions to PracticeUpdate:

  1. Predictive Value of Isolated High-Grade Prostatic Intraepithelial Neoplasia in Detecting Clinically Significant Prostate Cancer Risk
  2. Cribriform Architecture Prostatic Adenocarcinoma in Needle Biopsies Is a Strong Independent Predictor for Lymph Node Metastases in Radical Prostatectomy
  3. Prognostic Impact of Intraductal Carcinoma of the Prostate
  4. Prostatic Ductal Adenocarcinoma Controlled for Cancer Grade and Tumor Volume Does Not Impact Radical Prostatectomy Outcomes
  5. Positive Surgical Margin Length, Gleason Grade at the Margin, and Biochemical Recurrence in Prostate Cancer
  6. The Prognostic Value of Zonal Origin and Extraprostatic Extension of Prostate Cancer for Biochemical Recurrence After Radical Prostatectomy
  7. Grade Grouping System Provides Improved Predictions of Pathologic and Early Oncologic Outcomes Over Gleason Score
  8. Gleason Score 5 + 3 = 8 Prostate Cancer
  9. Easing Out Gleason: Time for a New Grading System
  10. A Contemporary Prostate Cancer Grading System

Recently Updated